Molotinib

Molotinib uses and dosage

Molotinib (Momelotinib), generic OJJAARA is a prescription medicine used to treat treatment of intermediate to high-risk myelofibrosis (MF) in adults with anemia. This includes primary myelofibrosis (PMF) as well as secondary myelofibrosis arising from post-polycythemia vera (PV) or post-essential thrombocythemia (ET). Molotinib manufactured by TLPH Pharma Ltd. in Laos. Momelotinib has to take orally once a daily with or without food as directed by patients doctor.

Molotinib side effects

The most common side effects of Momelotinib are: Thrombocytopenia (low platelet counts), Hemorrhage (bleeding), Bacterial infections, Fatigue, Dizziness, Diarrhea, Nausea.

Originator brand

OJJAARA by GLAXOSMITHKLINE

Made by

TLPH Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.